Other News To Note
Wednesday, June 20, 2012
Coronado Biosciences Inc., of Burlington, Mass., reported that the FDA granted orphan drug status to its biologic CNDO-109 for the treatment of acute myeloid leukemia (AML).
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.